Preliminary findings from our group indicate that cholesterol can enhance AR expression by modulating p160 coactivators, supporting the hypothesis of an interface between metabolic and epigenetic factors in BPH pathophysiology [13]. The gene discussed is AR; the disease is benign prostatic hyperplasia.